Nolicin (Norfloxacin)

Norfloxacin, the active ingredient in Nolicin, is a fluoroquinolone presented as an oral tablet for systemic use. It is employed to treat bacterial infections of the urinary tract, acute bacterial prostatitis, gastroenteritis and certain respiratory tract infections in adult patients.

GNH USA supplies Nolicin as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics worldwide through regulated distribution channels. The company adheres to stringent quality standards and offers reliable logistics for global markets, ensuring timely delivery.

Nolicin (norfloxacin) is indicated for bacterial infections affecting several organ systems.

- Urinary tract infections: eradicates susceptible Gram‑negative and some Gram‑positive pathogens, relieving symptoms and preventing recurrence. - Acute bacterial prostatitis: achieves bacterial clearance in the prostate, improving pain and urinary function. - Gastroenteritis caused by susceptible bacteria: reduces bacterial load in the intestine, alleviating diarrhea and abdominal discomfort. - Respiratory tract infections: treats susceptible strains causing bronchitis or pneumonia, aiding recovery of respiratory function.

Norfloxacin may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Diarrhea: loose stools, usually self‑limiting. - Headache: transient cranial discomfort.

Serious or Rare Side Effects: - Tendon rupture: risk of Achilles or other tendon tears. - QT interval prolongation: potential cardiac arrhythmia. - Severe allergic reactions: anaphylaxis or angioedema.

When prescribing norfloxacin, clinicians should consider several precautionary measures to minimize risks. - Renal impairment: adjust dose or monitor renal function in patients with reduced clearance. - Hepatic disease: use with caution in severe liver dysfunction. - Concomitant QT‑prolonging drugs: avoid or monitor cardiac rhythm. - History of tendon disorders: avoid use in patients with prior tendon injury. - Pregnancy and lactation: safety not established; use only if benefits outweigh risks. - Store at ambient temperature: keep below 25 °C, in original packaging, protected from moisture and light.

Norfloxacin interacts with several medicines; awareness of the interaction level guides clinical decisions.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: markedly reduce absorption; separate dosing by at least 2 hours. - Warfarin: may enhance anticoagulant effect, increasing INR; close monitoring required. - Theophylline: increased plasma levels leading to toxicity.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase risk of CNS stimulation. - Corticosteroids: combined use may raise tendon rupture risk. - Diabetic agents (e.g., insulin, sulfonylureas): potential for hypoglycemia; monitor blood glucose.